| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |